|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/36 | |
| A61K 38/37 | |||
| A61K 47/36 | |||
| A61P 7/04 | |||
| A61K 47/42 | |||
| A61K 9/00 |
| (11) | Patento numeris | 2768522 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12777895.9 |
| Europos patento paraiškos padavimo data | 2012-10-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-08-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-07-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2012/070615 |
| Data | 2012-10-18 |
| (87) | Numeris | WO 2013/057167 |
| Data | 2013-04-25 |
| (30) | Numeris | Data | Šalis |
| 11185648 | 2011-10-18 | EP | |
| 201161548606 P | 2011-10-18 | US |
| (72) |
METZNER, Hubert., DE
ZOLLNER, Sabine., CH
|
| (73) |
CSL Behring GmbH,
Emil-von-Behring-Strasse 76, 35041 Marburg,
DE
|
| (54) | USE OF SULFATED GLYCOSAMINOGLYCANS FOR IMPROVING THE BIOAVAILABILITY OF FACTOR VIII |
| USE OF SULFATED GLYCOSAMINOGLYCANS FOR IMPROVING THE BIOAVAILABILITY OF FACTOR VIII |